Ignite Creation Date:
2025-12-24 @ 12:14 PM
Ignite Modification Date:
2026-03-10 @ 11:28 PM
Study NCT ID:
NCT04213261
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-01
First Post:
2019-12-02
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
Sponsor:
Castle Creek Biosciences, LLC.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2037-07
Completion Date Type:
ESTIMATED
First Submit Date:
2019-12-02
First Submit QC Date:
None
Study First Post Date:
2019-12-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-01-17
Results First Submit QC Date:
None
Results First Post Date:
2024-04-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-28
Last Update Post Date:
2024-04-01
Last Update Post Date Type:
ACTUAL